| Literature DB >> 30622218 |
Keisuke Hitachi1, Masashi Nakatani1, Akihiko Takasaki2, Yuya Ouchi3, Akiyoshi Uezumi1, Hiroshi Ageta1, Hidehito Inagaki3, Hiroki Kurahashi3, Kunihiro Tsuchida4.
Abstract
Promoter-associated long non-coding RNAs (lncRNAs) regulate the expression of adjacent genes; however, precise roles of these lncRNAs in skeletal muscle remain largely unknown. Here, we characterize a promoter-associated lncRNA, Myoparr, in myogenic differentiation and muscle disorders. Myoparr is expressed from the promoter region of the mouse and human myogenin gene, one of the key myogenic transcription factors. We show that Myoparr is essential both for the specification of myoblasts by activating neighboring myogenin expression and for myoblast cell cycle withdrawal by activating myogenic microRNA expression. Mechanistically, Myoparr interacts with Ddx17, a transcriptional coactivator of MyoD, and regulates the association between Ddx17 and the histone acetyltransferase PCAF Myoparr also promotes skeletal muscle atrophy caused by denervation, and knockdown of Myoparr rescues muscle wasting in mice. Our findings demonstrate that Myoparr is a novel key regulator of muscle development and suggest that Myoparr is a potential therapeutic target for neurogenic atrophy in humans.Entities:
Keywords: DEAD box protein; chromatin; myogenesis; transcriptional regulation
Mesh:
Substances:
Year: 2019 PMID: 30622218 PMCID: PMC6399612 DOI: 10.15252/embr.201847468
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807